Neogenomics Inc (NASDAQ:NEO)

4.80
Delayed Data
As of Mar 30
 +0.08 / +1.69%
Today’s Change
2.95
Today|||52-Week Range
6.10
+15.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues18.2M20.7M23.2M25.0M
 
 
 
 
 
Cost of Goods Sold8.3M9.2M11.4M13.5M
 
 
 
 
 
Depreciation And Amortization1.2M1.3M1.6M--
 
 
 
 
 
Operating ExpensesGross Income8.7M10.2M10.2M11.5M
 
 
 
 
 
General Expenses8.3M9.6M10.3M10.2M
 
 
 
 
 
Research And Development572.0K578.0K925.0K414.0K
 
 
 
 
 
Total Operating Expenses17.8M20.1M23.3M23.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income394.0K578.0K-73.0K1.3M
 
 
 
 
 
Interest Expense On Debt265.0K253.0K218.0K193.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income129.0K325.0K-291.0K1.1M
 
 
 
 
 
Income Taxes-27.0K-51.0K0.00-79.0K
 
 
 
 
Net Income102.0K274.0K-291.0K1.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.3M49.9M54.4M60.0M
 
 
 
 
 
Shares To Calculate EPS Diluted53.5M53.7M54.4M62.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.01-$0.01$0.02
 
 
 
 
EPS Diluted$0.00$0.01-$0.01$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account